Literature DB >> 5173353

Hereditary bilateral acoustic neuroma (central neurofibromatosis).

D F Young, R Eldridge, G T Nager, F H Deland, J McNew.   

Abstract

Fifty-five members of a kindred have bilateral acoustic neuroma. The trait is autosomal dominant with high penetrance. Onset is about age 20; survival varies from two to 42 years. In screening members, vestibular abnormalities are most consistently observed, but complete audiometric studies and brain scan are important, because no single study is diagnostically sufficient in all cases. Peripheral signs suggesting neurofibromatosis are rare, but other CNS tumors, often asymptomatic, are common suggesting this trait may represent a "central" form of neurofibromatosis.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5173353

Source DB:  PubMed          Journal:  Birth Defects Orig Artic Ser        ISSN: 0547-6844


  5 in total

1.  A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity.

Authors:  D G Evans; S M Huson; D Donnai; W Neary; V Blair; D Teare; V Newton; T Strachan; R Ramsden; R Harris
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

Review 2.  Clinical and genetic patterns of neurofibromatosis 1 and 2.

Authors:  N K Ragge
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

3.  Dural ectasia as a cause of widening of the internal auditory canals in neurofibromatosis.

Authors:  J C Egelhoff; W S Ball; R B Towbin; R S Seigel; C G Eckel
Journal:  Pediatr Radiol       Date:  1987

4.  Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors.

Authors:  R K Wolff; K A Frazer; R K Jackler; M J Lanser; L H Pitts; D R Cox
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

5.  Neurilemmomatosis and neurofibromatosis syndrome.

Authors:  D Kumar; W R Timperley
Journal:  Indian J Pediatr       Date:  1985 Sep-Oct       Impact factor: 1.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.